WI SB764

Caps patient cost-sharing for epinephrine delivery systems (such as EpiPens) at $60 maximum for two doses under health insurance policies and self-insured governmental health plans

Applies to all FDA-approved epinephrine devices containing premeasured doses used to treat life-threatening allergic reactions, regardless of device type or brand

Covers disability insurance policies and self-insured plans of the state, counties, cities, villages, towns, and school districts that provide coverage for medically necessary epinephrine

Permits insurers to charge less than $60 or impose no cost-sharing at all, but prohibits exceeding the $60 cap

Takes effect on the first day of the 4th month after publication, with delayed implementation for plans affected by existing collective bargaining agreements